"'Over the past 10 years, technology has become part of the conversation in almost every domain,' says Jason Schultz, adding, 'Where is it not a factor or an issue when you’re thinking about social justice and public interest?'"
"Vintage Modern", NYU Law Magazine, 2019
Press Highlights:
-
Opinion: The FDA is in desperate need of some soul-searching (Washington Post, Jun. 17, 2021)
-
Pharma’s secrecy hinders global COVID-19 vaccination. Joe Biden could fix that. (Boston Globe, Jun. 1, 2021)
-
We Can’t Trust Big Pharma To Make Enough Vaccines (The Nation, May 31, 2021)
-
COVID-19 lesson: New FDA chief, when chosen, must crack down on clinical trial transparency (Baltimore Sun, May 13, 2021)
-
Vaccine companies and the U.S. government snubbed WHO initiative to scale up global manufacturing (LA Times, Apr. 30, 2021)
-
FDA Enforces Clinical Trial Transparency Following UAEM’s Work (UAEM, Apr. 28, 2021)
-
For the first time, the FDA may fine a drug maker for failing to post clinical trial results (STAT, Apr. 28, 2021)
-
Vaccine IP Enforcement Takes Stage in Global Immunization Fight (Bloomberg Law, Apr. 27, 2021)
-
NIH Scientist Who Developed Key Vaccine Technology Says Patent Gives US Leverage Over Big Pharma (Common Dreams, Apr. 23, 2021)
-
Moderna’s Pledge Not to Enforce the Patents on Their COVID-19 Vaccine Is Worthless (Jacobin, Apr. 22, 2021)
-
Law professors call for FDA to disclose all safety and efficacy data for drugs (Endpoints, Apr. 21, 2021)
-
Vaccine patent gives US government ‘leverage’ over manufacturers (Financial Times, Apr. 21, 2021)
-
The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research (STAT, Mar. 31, 2021)
-
Clinic students author a guide to a law that could prioritize public health over private profits (NYU Law News, Mar. 30, 2021)
-
Covid-19 Vaccine Deal-Making Is Fleeting Game Changer for Pharma, (Bloomberg Law, Mar. 29, 2021)
-
Coalition Calls on Biden to Use US-Owned Patent to Share Covid Vaccine With the World, (Common Dreams, Mar. 26, 2021)
-
HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access (STAT, Mar. 25, 2021)
-
Rich Countries Signed Away a Chance to Vaccinate the World (NY Times, Mar. 21, 2021)
-
Expanding Access to Life-Saving Drugs: Priceless (NYU News, Mar. 9, 2021)
-
Section 1498 May Be a Potential Government Remedy for Approved, Unlaunched Etanercept Biosimilars
(Biosimilars Review and Report, Jan. 28, 2021) -
Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers (KHN, Jan. 27, 2021)
-
This academic published a manual for using a little-known federal law for lowering drug prices (STAT, Jan. 26, 2021)
-
Public health experts push vaccine makers, HHS to release Covid-19 trial protocols (STAT, Oct. 20, 2020)
-
FDA Redactions Upheld in FOIA Suit for Drug Approval Documents (Bloomberg Law, Oct. 6, 2020)
- Covid-19 drug rationed in the US is plentiful in developing countries (CNN, Sep. 9, 2020)
- FDA may fine clinical trial sponsors that don’t report data (BMJ, Aug. 24, 2020)
- FDA finalizes penalties for clinical trial sponsors that don’t share data, but critics say they fall short (STAT News, Aug. 18, 2020)
- Following court ruling, NIH warns drug and device companies to post missing trial data (STAT News, Aug. 4, 2020)
- Sens. Elizabeth Warren and Bernie Sanders slam Trump for giving Gilead ‘windfall’ deal for coronavirus drug (CNBC, Jul. 16, 2020) (link to remdesivir report in letter from Senators)
- A powerful law gives HHS the right to take control of remdesivir manufacturing and distribution (STAT News, Jul. 2, 2020)
- Treatments don’t work if we can’t afford them: the global need for open and equitable access to remdesivir (BMJ, Jun 3, 2020) (link to remdesivir report)
- Big Pharma Attacks Efforts to Guard Against Coronavirus Price Gouging (The Intercept, Jun. 2, 2020) (link to remdesivir report)
- Activists Say Gov't Should Have Rights To Remdesivir Patents (Law 360, May 27, 2020)
- Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price (Washington Post, May 26, 2020)
- Who’s Afraid of Section 1498?: Government Patent Use as Versatile Policy Tool (Written Description, Apr. 24, 2020)
- The tension between public health and patents in the era of Covid-19 (STAT News, Apr. 14, 2020)
- Lost opportunities from FDA, NIH inaction when sponsors fail to report clinical trial results (STAT News, Apr. 13, 2020)
- NYU and Yale Collaboration Leads to Ruling that Will Reveal Decade of Undisclosed Clinical Trial Data (NYU News, Apr. 3, 2020)
- Judge: Feds must open trial data access (Outsourcing-Pharma, Mar. 3, 2020)
- Ten years of clinical trial data cannot legally be hidden from the public, US court rules (BMJ, Mar. 2, 2020)
- Judge rules to release clinical trial data (Yale Daily News, Mar. 2, 2020)
- Missing clinical trial data must be made public, federal judge says (Science, Feb. 26, 2020)
- Judge orders HHS to fill 10-year data gap on Clinicaltrials.gov (Bioworld, Feb. 26, 2020)
- Update on Transparency at ClinicalTrials.gov (American Council on Science and Health, Feb. 26, 2020)
- Federal judge rules clinical trial sponsors must publish a decade’s worth of missing data (STAT News, Feb. 25, 2020)
- Transparency Advocates Win Victory for Public Access to Clinical Trial Data (Yale Law/NYU Law Joint Press Release, Feb. 25, 2020)
- Facebook Ads Cause Patients to Stop, Switch HIV Prevention Drug (Bloomberg Law, Dec. 16, 2019)
- U.S. Patent Office removes lawyer from high-profile case involving a Gilead HIV medicine (STAT News, Dec. 13, 2019)
- A USPTO legal adviser is off controversial Gilead HIV case after activists allege tweets show bias (Endpoints News, Dec. 13, 2019)
- Activists say a patent office lawyer’s tweets showed ‘bias’ in favor of Gilead in HIV drug case (STAT News, Dec. 12, 2019)
- Technology Law and Policy Clinic Project Leads to First-of-Its-Kind Brief in “Geofence” Warrants Case (Engelberg Center on Innovation Law & Policy, Dec. 12, 2019)
- Sanders and Ocasio-Cortez say company seeking HIV patent extension 'deceitful and immoral' (The Guardian, Dec. 9, 2019)
- Gilead Fends Off Monopoly Accusation from HIV Advocacy Group PrEP4All (PharmaLive, Dec. 6, 2019)
- Activists seek to block a Gilead patent extension on a lucrative HIV drug (STAT News, Dec. 6, 2019)
- Gilead delayed safer HIV drug to extend monopoly profits, advocates allege (Washington Post, Dec. 5, 2019)
- PrEP4All Claims Gilead Held Back Safer HIV Drug (Advocate, Dec. 5, 2019)
- Police used Google location data to find accused bank robber. He says that's illegal. (NBC News, Nov. 20, 2019)
- U.S. sues Gilead, claiming it owns HIV PrEP patent (NBC News, Nov. 7, 2019)
- Gilead pledges to donate Truvada despite HHS patent lawsuit (Modern Healthcare, Nov. 7, 2019)
- University legal clinics, professors form national network to advance free speech and government transparency (Reporters Committee for Freedom of the Press, Sep. 4, 2019)
- How to lift the veil off hidden algorithms (Fast Company, Jan. 28, 2019)
- Every other industry has a safety label. Now tech does, too (Fast Company, Dec. 7, 2018)
- ACLU asks court to release a secret order forcing Facebook to wiretap Messenger (Tech Crunch, Nov. 28, 2018)
- NYU Law Panels: What Will Be the True Impact of Legal Tech on the Future of the Legal Industry? (Thomson Reuters, Nov. 21, 2018)
- OSHWA Certification 2.0 is Here (Open Source Hardware Association, Sep. 27, 2018)
- What is AI technology? Experts don't always agree (ABA Journal, Apr. 23, 2018)
- Innovation and Tradition: A Survey of Intellectual Property and Technology Legal Clinics (UPenn Law Faculty Scholarship, 2018)
-
Why AI Isn’t Going to Solve Facebook’s Fake News Problem (The Verge, Apr. 5, 2018)
- Don’t Ask Wikipedia to Cure the Internet (Wired, Mar. 16, 2018)
- Bias Mitigation Using the Copyright Doctrine of Fair Use (Fast Forward Labs Newsletter, Oct. 26, 2017)
- A Quick and Dirty Guide to Open Source Hardware Licensing* (MichaelWeinberg.org, Oct. 2017)
-
What Are the Ethics of Using AI for Journalism? (Nieman Lab, Jun. 14, 2017)
-
On Frank Ocean and "Fearless Girl," or Who Owns Art? (Nylon, May 11, 2017)
- Bad Copyright Laws Are Creating Biased AI (Vocativ, Apr. 5, 2017)
- Wikipedians: The Heroes the Internet Needs (Video Interview with Amanda Levendowski and Yilu Zhang, Elite Daily, Jan. 2017)
- Using Wikipedia in Court (Podcast interview with Amanda Levendowski, This Week in Law, Aug. 2016)
- Canary Watch One Year Later (EFF, May 25, 2016)
- Every College Should Issue a Transparency Report About Government Requests for Student Data (Slate, Sep. 18, 2015)
- Weaponizing code: America's quest to control the exploit market (Engadget, May 29, 2015)
- EFF Fights for Common Sense, Again, in DMCA Rulemaking (EFF, Nov. 3, 2014)